TytoCare, the healthcare industry's first all-in-one modular device and telehealth platform for AI-powered, on-demand remote medical examinations, today announced that it has raised $50M in a significantly oversubscribed Series D extension round, doubling the company's valuation. This funding comes on the heels of TytoCare raising $50M in April 2020, making for $100M raised over the last 10 months. Doubling down on its previous investment, Insight Partners led the extension with participation from new growth investors Tiger Global Management and Qumra Capital and existing investors Qualcomm Ventures LLC, Olive Tree Ventures, and Shenzhen Capital Group Company, bringing the company's total funding to $155M to date.

TytoCare is a telehealth company using AI to transform primary care by putting health in the hands of consumers. TytoCare seamlessly connects people to clinicians to provide the best virtual home examination and diagnosis solutions. Its solutions are designed to enable a comprehensive medical exam from any location and include a hand-held, all-in-one tool for examining the heart, lungs, skin, ears, throat, abdomen, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use for patients and insights for healthcare providers. Co-founded by Dedi Gilad and Ofer Tzadik in 2012, TytoCare has FDA and CE clearances and has partnered with over 100 major health systems, health plans, and strategic partners in the U.S., Europe, Asia, and Israel.